Study title:
Longo-D-L, Young-R-C, Wesley-M, Hubbard-S-M, Duffey-P-L, Jaffe-E-S, DeVita-V-T-Jr. Twenty years of MOPP therapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Sep 1986, vol. 4, no. 9, p. 1295-306, ISSN: 0732-183X.Longo-D-L, Young-R-C, Wesley-M, Hubbard-S-M, Duffey-P-L, Jaffe-E-S, DeVita-V-T-Jr. Twenty years of MOPP therapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Sep 1986, vol. 4, no. 9, p. 1295-306, ISSN: 0732-183X.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|